Ceretas Ltd. operates as a medical technology company. It develops a device with non-invasive therapeutic ultrasound for the treatment of Alzheimer's disease and other neurodegenerative conditions. The company was founded by Rachel de las Heras, Ryan Laws, and Sam Wetzler in October 2024 and is headquartered in Brisbane, Australia.